Acute exacerbations of chronic bronchitis

References

• Woolcock AJ. Epidemiology of chronic airways disease. Chest 1989; 96(3 Suppl): 302–306S
   Web of Science ®Google Scholar
• Chodosh S. Treatment of acute exacerbations of chronic bronchitis: state of the art. Am J Med 1991; 91(Suppl 6A): 87–92S
   Web of Science ®Google Scholar
• Irwin RS, Erickson AD, Pratter MR, et al. Prediction of tracheobronchial colonization in current cigarette smokers with chronic obstructive bronchitis. J Infect Dis 1982; 145(2): 234–41
   PubMed Web of Science ®Google Scholar
• Chodosh S. Acute bacterial exacerbations in bronchitis and asthma. Am J Med 1987; 82(Suppl 4A): 154–63
   PubMed Web of Science ®Google Scholar
• Committee on the Aetiology of Chronic Bronchitis. Definition and classification of chronic bronchitis for clinical and epidemiological purposes: report to the Medical Research Council. Lancet 1965; 1(7389): 775–9
   PubMed Web of Science ®Google Scholar
• Brown RB. Managing exacerbations of chronic bronchitis. J Respir Dis 1990; 2(4)353–64
   Google Scholar
• Anthonisen NR, Man freda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106(2): 196–204
   PubMed Web of Science ®Google Scholar
• Pines A. Trimethoprim-sulfamethoxazole in the treatment and prevention of purulent exacerbations of chronic bronchitis. J Infect Dis 1973; 128: (Suppl): 706–9
   PubMed Web of Science ®Google Scholar
• Brown RB, Levin J. Bronchopulmonary infections in the elderly. II. Diagnosis, treatment, and prevention. Infect Med 1991; 5–6, 44–8
   Google Scholar
• Doern GV, Jorgensen JH, Thornsberry C, et al. Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study. Diagn Microbiol Infect Dis 1986; 4(2): 95–107
   PubMed Web of Science ®Google Scholar
• Wallace RJ Jr, Steele LC, Brooks DL, et al. Ampicillin, tetracycline, and chloramphenicol resistant Haemophilus influenzae in adults with chronic lung disease: relationship of resistance to prior antimicrobial therapy. Am Rev Respir Dis 1988; 137(3): 695–9
   PubMed Web of Science ®Google Scholar
• Struelens MJ, Nonhoff C, Lontie M, et al. In vitro activity of commonly used oral antimicrobial agents against community isolates of respiratory pathogens. Acta Clin Belg 1991; 46(5): 283–9
   PubMed Web of Science ®Google Scholar
• Sweeney KG, Verghese A, Needham CA. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains. Antimicrob Agents Chemother 1985; 27(4): 499–502
   PubMed Web of Science ®Google Scholar
• Nicotra B, Rivera M, Luman JI, et al. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch Intern Med 1986; 146(5): 890–3
   PubMedGoogle Scholar
• Geddes AM. Cefpodoxime proxetil in the treatment of lower respiratory tract infections. Drugs 1991; 42(Suppl 3): 34–40
   PubMedGoogle Scholar
• Periti P, Novelli A, Schildwachter G, et al. Efficacy and tolerance of Cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis. J Antimicrob Chemother 1990; 26(Suppl E): 63–9
   PubMed Web of Science ®Google Scholar
• Finn A, Straughn A, Meyer M, et al. Effect of dose and food on the bioavailability of cefuroxime axetil. Biopharm Drug Dispos 1987; 8(6): 519–26
   PubMed Web of Science ®Google Scholar
• American Society of Hospital Pharmacists. AHFS drug information 93. Bethesda, MD; 1993; 98–9, 103–9, 124–6, 148–54, 186
   Google Scholar
• Verghese A, Roberson D, Kalbfleisch JH, et al. Randomized comparative study of Cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. Antimicrob Agents Chemother 1990; 34(6): 1041–4
   PubMed Web of Science ®Google Scholar
• Pelletier LL Jr. Review of the experience with cefprozil for the treatment of lower respiratory tract infections. Clin Infect Dis 1992; 14(Suppl 2): S238–43
   PubMed Web of Science ®Google Scholar
• Cooper TJ, Ladusans E, Williams PE, et al. A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections. J Antimicrob Chemother 1985; 16(3): 373–8
   PubMed Web of Science ®Google Scholar
• Nolen TM, Phillips HL, Hutchinson J, et al. Comparison of cefuroxime axetil and cefaclor for patients with lower respiratory tract infections presenting to a rural family practice clinic. Curr Ther Res 1988; 44(5): 821–9
   Web of Science ®Google Scholar
• Schleupner CJ, Anthony WC, Tan J, et al. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections. Arch Intern Med 1988; 148(2): 343–8
   PubMedGoogle Scholar
• Landau Z, Schlaffer F, Pitlik S. Cefuroxime axetil vs. Augmentin for the treatment of acute bronchitis and exacerbation of chronic obstructive pulmonary disease. Isr J Med Sci 1992; 28(11): 797–9
   PubMedGoogle Scholar
• Brambilla C, Kastanakis S, Knight S, et al. Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections. Eur J Clin Microbiol Infect Dis 1992; 11(2): 118–24
   PubMed Web of Science ®Google Scholar
• Dere WH, Farlow D, Therasse DG, et al. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis. Clin Ther 1992; 14(1): 41–53
   PubMed Web of Science ®Google Scholar
• Spiritus E, Devcich K, Drnec J, et al. Clarithromycin vs cefaclor for acute exacerbations of bronchitis. Scientific poster presented at the First International Conference on the Macrolides, Azalides and Streptogramins. Santa Fe, NM: 1992Jan: 7
   Google Scholar
• Prokocimer P. An evaluation of clarithromycin and cefixime for lower respiratory tract infections. Scientific poster presented at the First International Conference on the Macrolides, Azalides and Streptogramins. Santa Fe, NM: 1992 Jan: 63
   Google Scholar
• Jenkinson S, Anzueto A, Smith B, et al. Clarithromycin compared with cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis. Scientific poster presented at the First International Conference on the Macrolides, Azalides and Streptogramins. Santa Fe, NM: 1992 Jan
   Google Scholar
• Mertens JC, van Barneveld PW, Asin HR, et al. Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis. Antimicrob Agents Chemother 1992; 36(7): 1456–9
   PubMed Web of Science ®Google Scholar
• Daniel R and European Azithromycin Study Group. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. J Int Med Res 1991; 19(5): 373–83
   PubMed Web of Science ®Google Scholar
• Cassell GH, Drnec J, Waites KB, et al. Efficacy of clarithromycin against Mycoplasma pneumoniae. J Antimicrob Chemother 1991; 27(Suppl A): 47–59
   PubMed Web of Science ®Google Scholar
• Renaudin H, Bebear C. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Eur J Clin Microbiol Infect Dis 1990; 9(11): 838–41
   PubMed Web of Science ®Google Scholar
• Piscitelli SC, Danziger LH, Rodvold KA. Clarithromycin and azithromycin: new macrolide antibiotics. Clin Pharm 1992; 11(2): 137–52 [Erratum, Clin Pharm 1992; 11(4): 308]
   PubMedGoogle Scholar
• Chodosh S, Tuck J, Stottmeier KD, et al. Comparison of ciprofloxacin with ampicillin in acute infectious exacerbations of chronic bronchitis: a double-blind crossover study. Am J Med 1989; 87(Suppl 5A): 107–12S
   Web of Science ®Google Scholar
• Wollschlager CM, Raoof S, Khan FA, et al. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections. Am J Med 1987; 82(4A): 164–8
   PubMed Web of Science ®Google Scholar
• Arcieri G, Griffith E, Gruenwaldt G, et al. Ciprofloxacin: an update on clinical experience. Am J Med 1987; 82(Suppl 4A): 381–6
   PubMed Web of Science ®Google Scholar
• Stocks JM, Wallace RJ Jr, Griffith DE, et al. Ofloxacin in community-acquired lower respiratory infections: a comparison with amoxicillin or erythromycin. Am J Med 1989; 87(6C): 52–6S
   Google Scholar
• Punakivi L, Kerstinen T, Backman R, et al. Oral ofloxacin once daily and doxycycline in the treatment of acute exacerbations of chronic bronchitis. Scand J Infect Dis Suppl 1990; 68: 41–5
   PubMedGoogle Scholar
• Chodosh S. Use of quinolones for the treatment of acute exacerbations of chronic bronchitis. Am J Med 1991; 91(Suppl 6A): 93–100S
   Web of Science ®Google Scholar